EMA Panel Endorses Novavax's (NVAX) COVID vaccine for Full Approval

Novavax NVAX announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for its protein-based COVID-19 vaccine, Nuvaxovid (NVX-CoV2373).